Effect of acute and chronic photoperiod modulation on pentylenetetrazole-induced clonic seizure threshold in mice

Epilepsy Research

Volumn 82, Issue 1, 2008, Pages 64-69

  Tahsili Fahadan, Pouya ^a   Yahyavi Firouz Abadi, Noushin ^a   Riazi, Kiarash ^a   Ghahremani, Mohammad Hossein ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Circadian rhythm; Clonic seizure threshold; Melatonin; Mice; Pentylenetetrazole; Photoperiod

Indexed keywords

MELATONIN; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG EFFECT; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHOTOPERIODICITY; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; ANIMAL; CHEMICALLY INDUCED DISORDER; CIRCADIAN RHYTHM; DISEASE PREDISPOSITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PINEAL BODY; RADIATION EXPOSURE; SEIZURE;

ANIMALS; CIRCADIAN RHYTHM; DISEASE SUSCEPTIBILITY; MALE; MELATONIN; MICE; PENTYLENETETRAZOLE; PHOTOPERIOD; PINEAL GLAND; SEIZURES;

EID: 64149128275     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.07.006     Document Type: Article

References (48)

1. Acuna-Castroviejo D., Escames G., Macias M., Munoz Hoyos A., Molina Carballo A., Arauzo M., and Montes R. Cell protective role of melatonin in the brain. J. Pineal Res. 19 (1995) 57-63
2. Bastlund J.F., Jennum P., Mohapel P., Penschuck S., and Watson W.P. Spontaneous epileptic rats show changes in sleep architecture and hypothalamic pathology. Epilepsia 46 (2005) 934-938
3. Bazil C.W., and Walczak T.S. Effects of sleep and sleep stage on epileptic and nonepileptic seizures. Epilepsia 38 (1997) 56-62
4. Bikjdaouene L., Escames G., Leon J., Ferrer J.M., Khaldy H., Vives F., and Acuna-Castroviejo D. Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures. J. Pineal Res. 35 (2003) 54-60
5. Borowicz K.K., Kaminski R., Gasior M., Kleinrok Z., and Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur. Neuropsychopharmacol. 9 (1999) 85-90
6. Brainard G.C., Rollag M.D., and Hanifin J.P. Photic regulation of melatonin in humans: ocular and neural signal transduction. J. Biol. Rhythms 12 (1997) 537-546
7. Brzezinski A. Melatonin in humans. N. Engl. J. Med. 336 (1997) 186-195
8. Champney T.H., and Champney J.A. Novel anticonvulsant action of chronic melatonin in gerbils. Neuroreport 3 (1992) 1152-1154
9. Champney T.H., Hanneman W.H., Legare M.E., and Appel K. Acute and chronic effects of melatonin as an anticonvulsant in male gerbils. J. Pineal Res. 20 (1996) 79-83
10. Cortez M.A., Burnham W.M., and Hwang P.A. Infantile spasms: seasonal onset differences and zeitgebers. Pediatr. Neurol. 16 (1997) 220-224
11. Dawson D., and Encel N. Melatonin and sleep in humans. J. Pineal Res. 15 (1993) 1-12
12. Escames G., Macias M., Leon J., Garcia J., Khaldy H., Martin M., Vives F., and Acuna-Castroviejo D. Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum. J. Neuroendocrinol. 13 (2001) 459-466
13. Escames G., Leon J., Lopez L.C., and Acuna-Castroviejo D. Mechanisms of N-methyl-d-aspartate receptor inhibition by melatonin in the rat striatum. J. Neuroendocrinol. 16 (2004) 929-935
14. Eidman D.S., Benedito M.A., and Leite J.R. Daily changes in pentylenetetrazol-induced convulsions and open-field behavior in rats. Physiol. Behav. 47 (1990) 853-856
15. Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J. Clin. Neurophysiol. 9 (1992) 264-277
16. Golombek D.A., Pevet P., and Cardinali D.P. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci. Biobehav. Rev. 20 (1996) 403-412
17. A receptor ligands in pentylenetetrazole-kindled mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 105-113
18. Kaputlu I., and Uzbay T. l-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res. 753 (1997) 98-101
19. Kellaway P. Sleep and epilepsy. Epilepsia 26 (1985) S15-S30
20. Lapin I.P., Mirzaev S.M., Ryzov I.V., and Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J. Pineal Res. 24 (1998) 215-218
21. Löscher W., and Fiedler M. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res. 25 (1996) 3-10
22. Löscher W., Honack W., Fassbender D., and Nolting C.P.B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
23. Mandhane S.N., Aavula K., and Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure 16 (2007) 636-644
24. Masukawa T., and Nakanishi K. Circadian variation in enoxacin-induced convulsions in mice coadministered with fenbufen. Jpn. J. Pharmacol. 73 (1997) 175-177
25. Mevissen M., and Ebert U. Anticonvulsant effects of melatonin in amygdale-kindled rats. Neurosci. Lett. 257 (1998) 13-16
26. Molina-Carballo A., Munoz-Hoyos A., Rodriguez-Cabezas T., and Acuna-Castroviejo D. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Res. 52 (1994) 273-283
27. Molina-Carballo A., Munoz-Hoyos A., Reiter R.J., Sanchez-Forte M., Moreno-Madrid F., Rufo-Campos M., Molina-Font J.A., and Acuna-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J. Pineal Res. 23 (1997) 97-105
28. Munoz-Hoyos A., Sanchez-Forte M., Molina-Carballo A., Escames G., Martin-Medina E., Reiter R.J., Molina-Font J.A., and Acuna-Castroviejo D. Melatonin's role as an anticonvulsant and neural protector: experimental and clinical evidence. J. Child. Neurol. 13 (1998) 501-509
29. Oliverio A., Castellano C., Puglisi-Allegra S., and Renzi P. Diurnal variations in electroconvulsive shock-induced seizures: involvement of endogenous opioids. Neurosci. Lett. 57 (1985) 237-240
30. Pavlova M.K., Shea S.A., and Bromfield E.B. Day/night patterns of focal seizures. Epilepsy Behav. 5 (2004) 44-49
31. Philo R., and Reiter R.J. Characterization of pinealectomy induced convulsions in the Mongolian gerbil (Meriones unguiculatus). Epilepsia 19 (1978) 485-492
32. Poirel C. Circadian rhythms and temporal structure of the susceptibility to tonic-clonic seizures in the mouse. Brain Res. 301 (1984) 384-388
33. Poirel C., and Ennaji M. Circadian aspects of epileptic behavior in comparative psychophysiology. Psychol. Rep. 68 (1991) 783-801
34. Quigg M. Circadian rhythms: interactions with seizures and epilepsy. Epilepsy Res. 42 (2000) 43-55
35. Quigg M., and Straume M. Dual epileptic foci in a single patient express distinct temporal patterns dependent on limbic versus nonlimbic brain location. Ann. Neurol. 48 (2000) 117-120
36. Quigg M., Straume M., Menaker M., and Bertram E.H. Temporal distribution of partial seizures: comparison of an animal model with human partial epilepsy. Ann. Neurol. 43 (1998) 748-755
37. Quigg M., Clayburn H., Straume M., Menaker M., and Bertram E.H. Effects of circadian regulation and rest-activity state on spontaneous seizures in a rat model of limbic epilepsy. Epilepsia 41 (2000) 502-509
38. Redman J.R. Circadian entrainment and phase shifting in mammals with melatonin. J. Biol. Rhythms 12 (1997) 581-587
39. Rosenstein R.E., Chuluyan H.E., Diaz M.C., and Cardinali D.P. GABA as a presumptive paracrine signal in the pineal gland. Evidence on an intrapineal GABAergic system. Brain Res. Bull. 25 (1990) 339-344
40. Sanabria E.R., Scorza F.A., Bortolotto Z.A., Calderazzo-Filho L.S., and Cavalheiro E.A. Disruption of light-induced c-Fos immunoreactivity in the suprachiasmatic nuclei of chronic epileptic rats. Neurosci. Lett. 216 (1996) 105-108
41. Schapel G.J., Beran R.G., Kennaway D.L., McLoughney J., and Matthews C.D. Melatonin response in active epilepsy. Epilepsia 36 (1995) 75-78
42. Simonneaux V., and Ribelayga C. Generation of the melatonin message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol. Rev. 55 (2003) 325-395
43. Stewart L.S., Leung L.S., and Persinger M.A. Diurnal variation in pilocarpine-induced generalized tonic-clonic seizure activity. Epilepsy Res. 44 (2001) 207-212
44. Torshin V.I., and Vlasova I.G. Biorhythmologic aspects of seizure activity. Bull. Exp. Biol. Med. 132 (2001) 1025-1028
45. Wan Q., Man H.Y., Liu F., Braunton J., Niznik H.B., Pang S.F., Brown G.M., and Wang Y.T. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors. Nat. Neurosci. 2 (1999) 401-403
46. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., and Dehpour A.R. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res. 68 (2006) 103-113
47. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., and Dehpour A.R. Melatonin enhances the anticonvulsant and proconvulsant effects of morphine in mice: role for nitric oxide signaling pathway. Epilepsy Res. 75 (2007) 138-144
48. Yehuda S., and Mostofsky D.I. Circadian effects of beta-endorphin, melatonin, DSIP, and amphetamine on pentylenetetrazol-induced seizures. Peptides 14 (1993) 203-205